Hungary studies map resistance and virulence in canine otitis Pseudomonas
Bottom line
Two new papers from researchers at the University of Veterinary Medicine Budapest add a fuller picture of how Pseudomonas aeruginosa may persist in chronic canine otitis externa. In the new resistance-focused study, investigators analyzed 67 historical ear isolates from Hungary collected in 2010 and 2017, with matched long-read whole-genome assemblies for 59 isolates, and found broad multidrug resistance patterns alongside resistance genes and mobile-genetic-element contexts that help explain treatment difficulty. A companion Frontiers paper, published September 10, 2026, found that these same historical isolates shared a largely conserved virulence backbone, while differing in type III secretion effector profiles, suggesting that strains may vary meaningfully in pathogenic behavior even when their broader virulence architecture looks similar. (mdpi.com)
Why it matters: For veterinary professionals, the message is less about a single new resistance gene and more about the combination of persistence factors. P. aeruginosa otitis cases are often hard to clear because biofilm formation, intrinsic resistance, acquired resistance determinants, and chronic ear-canal changes can reinforce one another. The Hungarian dataset strengthens the case for culture-guided therapy, careful antimicrobial selection, and realistic expectations in recurrent cases, especially when empirical fluoroquinolone or aminoglycoside use may be undermined by strain-level resistance mechanisms. The virulence paper also suggests that isolates collected years apart may retain a stable core pathogenic toolkit, which helps explain why these infections can remain clinically stubborn over time. (mdpi.com)
What to watch: Watch for follow-up work linking these genomic findings to clinical outcomes, topical treatment performance, and antimicrobial stewardship guidance in canine ear disease. (mdpi.com)
Key facts
- Pathogen
- Pseudomonas aeruginosa
- Condition
- Canine otitis externa
- Study population
- Historical Hungarian canine ear isolates
- Collection years
- 2010 and 2017
- Resistance study sample size
- 67 isolates
- Genome assemblies
- 59 isolates with long-read whole-genome assemblies
- Virulence study sample size
- 52 high-quality genome-confirmed isolates
- Virulence finding
- Conserved virulence backbone with variable type III secretion effector profiles
- Publication date
- September 10, 2026
A pair of 2026 papers is sharpening the picture of why Pseudomonas aeruginosa remains one of the toughest pathogens in canine otitis externa. The latest study, published in Veterinary Sciences about two weeks ago, examined phenotypic susceptibility, resistance-associated genomic determinants, and the mobile-genetic-element context of historical Hungarian canine ear isolates collected in 2010 and 2017. Its companion paper in Frontiers in Veterinary Science, published September 10, 2026, adds the virulence side of the story, showing a conserved genomic backbone with meaningful isolate-to-isolate variation in type III secretion effectors. (mdpi.com)
That combination matters because canine otitis externa is common in practice, but P. aeruginosa is disproportionately associated with chronic, recurrent, and treatment-refractory cases. The Frontiers authors note that population-level studies estimate roughly 7% to 10% of dogs receive an otitis externa diagnosis in primary care, and they frame P. aeruginosa as especially difficult because it combines environmental persistence, intrinsic antimicrobial resistance, acquired resistance potential, and biofilm-associated growth. Review literature in the field echoes that point, describing Pseudomonas otitis as a problem shaped by moisture, inflammation, prior antimicrobial exposure, canal anatomy, and biofilm formation rather than by infection alone. (frontiersin.org)
In the resistance paper, the Hungarian team evaluated 67 isolates against 13 antimicrobial agents plus chlorhexidine, with 59 isolates supported by long-read whole-genome assemblies. According to the paper summary, the study’s goals were to map MIC distributions, compare the 2010 and 2017 subsets, identify resistance-associated genes, place those genes in mobile-genetic-element and plasmid-like contig context, and test whether specific genomic features or overall resistance-gene burden explained MIC variation. A related PubMed Central record for the same work reports a median modified multiple-antimicrobial-resistance index of 0.56, underscoring the heavy resistance burden in this collection. (mdpi.com)
The companion virulence study helps explain why resistance is only part of the clinical story. Among 52 high-quality genome-confirmed P. aeruginosa assemblies, the authors found 242 distinct virulence-associated genes, with 217 classified as core-like because they were present in at least 95% of genomes. Alginate, type IV pilus, flagellar, siderophore, phenazine, quorum-sensing, and type II, III, and VI secretion system backbones were broadly conserved. What varied most was type III effector content: exoT was present in all 52 isolates, exoY in 50, exoS in 49, and exoU in 4, with no statistically detectable difference in overall virulome composition between the 2010 and 2017 collections. (frontiersin.org)
The broader literature supports the relevance of those findings. Recent canine otitis reviews describe P. aeruginosa as a pathogen with strong biofilm-forming capacity and substantial intrinsic resistance, while another 2025–2026 veterinary study highlighted striking resistance rates among canine otitis isolates and emphasized the importance of targeted, culture-guided therapy. The Frontiers paper also places the Hungarian findings in a One Health context, citing recent genomic work showing that canine otitis-associated P. aeruginosa is genetically diverse and not confined to a simple host-restricted lineage. (pmc.ncbi.nlm.nih.gov)
Why it matters: For practicing veterinarians, this is a reminder that stubborn Pseudomonas ear infections are often the product of layered biology, not just a bad culture result. A pet parent may see repeated treatment failure as a medication issue, but these papers point to a more complex interaction between chronic ear-canal disease, biofilm persistence, stable virulence machinery, and resistance genes that may be embedded near mobile elements. That strengthens the rationale for cytology, culture and susceptibility testing in recurrent cases, deeper workups for primary causes such as allergic disease or conformational change, and cautious stewardship around repeat empirical antimicrobial use. It also suggests that isolates with similar broad virulence repertoires may still behave differently in tissue because of effector-level variation, which could eventually matter for prognosis or treatment response. (mdpi.com)
What to watch: The next step is whether these genomic and phenotypic findings can be tied to real-world case outcomes, especially topical therapy response, recurrence patterns, and stewardship recommendations. If follow-up studies connect specific resistance determinants or effector profiles to treatment failure, veterinary teams may get more actionable guidance on when to escalate diagnostics, how to interpret susceptibility patterns, and where antimicrobial choices are most likely to hold up over time. (mdpi.com)